Department of Breast Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 East Dongfeng Road, Guangzhou 510060, China.
School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Biomolecules. 2019 Aug 30;9(9):429. doi: 10.3390/biom9090429.
Circular RNA CDR1as/ciRS-7 functions as an oncogenic regulator in various cancers. However, there has been a lack of systematic and comprehensive analysis to further elucidate its underlying role in cancer. In the current study, we firstly performed a bioinformatics analysis of CDR1as among 868 cancer samples by using RNA-seq datasets of the MiOncoCirc database. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), gene set enrichment analysis (GSEA), CIBERSORT, Estimating the Proportion of Immune and Cancer cells (EPIC), and the MAlignant Tumors using Expression data (ESTIMATE) algorithm were applied to investigate the underlying functions and pathways. Functional enrichment analysis suggested that CDR1as has roles associated with angiogenesis, extracellular matrix (ECM) organization, integrin binding, and collagen binding. Moreover, pathway analysis indicated that it may regulate the TGF-β signaling pathway and ECM-receptor interaction. Therefore, we used CIBERSORT, EPIC, and the ESTIMATE algorithm to investigate the association between CDR1as expression and the tumor microenvironment. Our data strongly suggest that CDR1as may play a specific role in immune and stromal cell infiltration in tumor tissue, especially those of CD8+ T cells, activated NK cells, M2 macrophages, cancer-associated fibroblasts (CAFs) and endothelial cells. Generally, systematic and comprehensive analyses of CDR1as were conducted to shed light on its underlying pro-cancerous mechanism. CDR1as regulates the TGF-β signaling pathway and ECM-receptor interaction to serve as a mediator in alteration of the tumor microenvironment.
环状 RNA CDR1as/ciRS-7 在多种癌症中作为致癌调节剂发挥作用。然而,目前缺乏系统和全面的分析来进一步阐明其在癌症中的潜在作用。在本研究中,我们首先通过使用 MiOncoCirc 数据库的 RNA-seq 数据集,对 868 个癌症样本中的 CDR1as 进行了生物信息学分析。基因本体论 (GO)、京都基因与基因组百科全书 (KEGG)、基因集富集分析 (GSEA)、CIBERSORT、免疫和癌细胞估计 (EPIC) 和恶性肿瘤使用表达数据 (ESTIMATE) 算法被用于研究其潜在的功能和途径。功能富集分析表明,CDR1as 与血管生成、细胞外基质 (ECM) 组织、整合素结合和胶原蛋白结合有关。此外,通路分析表明它可能调节 TGF-β 信号通路和 ECM-受体相互作用。因此,我们使用 CIBERSORT、EPIC 和 ESTIMATE 算法来研究 CDR1as 表达与肿瘤微环境之间的关系。我们的数据强烈表明,CDR1as 可能在肿瘤组织中免疫细胞和基质细胞浸润中发挥特定作用,尤其是 CD8+T 细胞、活化的 NK 细胞、M2 巨噬细胞、癌相关成纤维细胞 (CAFs) 和内皮细胞。总的来说,对 CDR1as 进行了系统和全面的分析,以揭示其潜在的致癌机制。CDR1as 通过调节 TGF-β 信号通路和 ECM-受体相互作用,作为肿瘤微环境改变的介质。